Ritchie, J. P., Ramani, V. C., Ren, Y., Naggi, A., Torri, G., Casu, B., . . . Yang, Y. (2011). SST0001, a chemically modified heparin, inhibits myeloma growth and angiogenesis via disruption of the heparanase/syndecan-1 axis.
Styl cytowania ChicagoRitchie, Joseph P., et al. SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis Via Disruption of the Heparanase/syndecan-1 Axis. 2011.
Styl cytowania MLARitchie, Joseph P., et al. SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis Via Disruption of the Heparanase/syndecan-1 Axis. 2011.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..